LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.31623
 29.19 27.76 967 1863 0.5190 0.7951
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 30.90 27.76 895 2032 0.4404 0.7520
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 30.90 27.76 905 2032 0.4453 0.7551
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 30.90 27.76 993 2032 0.4886 0.7816
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 30.90 27.76 1031 2032 0.5073 0.7924
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 32.60 27.76 919 2235 0.4110 0.7380
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 32.60 27.76 927 2235 0.4146 0.7404
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 32.60 27.76 956 2235 0.4276 0.7489
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 32.60 27.76 988 2235 0.4419 0.7580
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 34.30 27.76 924 2449 0.3772 0.7200
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 34.30 27.76 936 2449 0.3821 0.7234
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 34.30 27.76 960 2449 0.3919 0.7302
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 34.30 27.76 978 2449 0.3992 0.7351
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 36.01 27.76 932 2662 0.3500 0.7052
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 36.01 27.76 943 2662 0.3541 0.7083
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 36.01 27.76 973 2662 0.3654 0.7164
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 36.01 27.76 992 2662 0.3725 0.7215
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 37.71 27.76 920 2877 0.3197 0.6868
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 37.71 27.76 929 2877 0.3228 0.6893
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 37.71 27.76 969 2877 0.3367 0.6999
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 37.71 27.76 988 2877 0.3433 0.7049
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 39.41 27.76 953 3105 0.3069 0.6813
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 39.41 27.76 964 3105 0.3104 0.6841
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 39.41 27.76 984 3105 0.3168 0.6892
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 39.41 27.76 1004 3105 0.3233 0.6942
MN20160318_Q01
H10